The corporate executive is comprised of the principal founders/directors with diverse experiences as successful entrepreneurs and experts in DNA-based technologies with vast experience in establishing, running and managing research and development.

B.V.Sc., M.Sc.(Microbiol) M.Sc.(Agric. Devel), Ph.D: Formerly Professor Department of Veterinary Microbiology and Pathology, College of Veterinary Medicine, Washington State University where he conducted research, and headed molecular diagnostics for the State of Washington at the Washington Animal Diseases Diagnostic Laboratory for 10 years until 2011. Fred is an international expert in infectious diseases and is known especially for pioneer research work and leadership that led to the discovery and development of a vaccine and quick diagnostic test for Contagious caprine pleuropneumonia (CCPP). The CCPP vaccine is presently sold all over Africa and beyond. Fred is at the helm of all ATCG technical aspects related to the success of delivering accurate and on-time DNA-based technologies. 

Prof. Fred R. Rurangirwa, Board Chairman/ Chief Operations Officer

A seasoned businessman and entrepreneur with over 10 years of international and regional experience spanning Africa, Asia and America.  Nziza has worked with and helped successfully establish and develop companies that span across education, media, entertainment and foreign trade. 

Mr. Nziza Rurangirwa, Managing Director

A co-pioneer of genetics research within Psychiatry in Uganda and sub-saharan Africa, where he lead the first work on determining the association between polymorphisms of the serotonin transporter gene with suicide among HIV+ adults in Uganda.  He is a proficient molecular scientist skilled in laboratory based research who received his MSc in Molecular Biology and Biotechnology from Makerere University.  In addition to running the technical facets within ATCG Solutions, Alan is undertaking his Ph.D from Stellenbosch University, Cape Town, in the field of human molecular genetics with a focus on epigenetic analysis.

Mr. Alan Kalungi,  Technology Advisor

Dr Munderi is a clinical scientist, recently Head of Program at the Medical Research Council unit, Uganda Virus Research Institute, where she led clinical trials on HIV treatment as well as implementation and health systems research studies. She serves on various national and international scientific advisory panels on public health policy and practice; and has earned recognition by the International Association of Providers of AIDS Care (IAPAC) as one of the leaders in the global public health response to the HIV/AIDS epidemic. She was previously a technical officer at the World Health Organisation in Geneva, and before that was a member of faculty, Department of Medicine, Makerere University Medical School in Kampala.  

Dr. Paula Munderi, MD, FRCP(Edin), Clinical & Safety Advisor.